Topic: Pharmaceutical Printing

12Jun/18

FDA Approves Genentech’s Rituxan For Pemphigus Vulgaris

The U.S. Food and Drug Administration (FDA) has approved Genentech’s Rituxan (rituximab) for the treatment of adults with moderate to severe pemphigus vulgaris (PV), a rare, serious, potentially life-threatening condition characterized by progressive painfulRead More…

11Aug/13

FDA May Soon Allow Generic Drug Makers to Update Safety Information On Pharmaceutical Labels

A Pharmaceutical Label Can Be Updated Sooner by Marie Ellis of Medical News Today Present Food and Drug Administration (FDA) regulations prohibit generic drug manufacturers from updating a product’s safety on theRead More…